A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation

E. Olavarria, M. Hassan, A. Eades, C. Nilsson, A. Timms, J. Matthews, C. Craddock, E. Kanfer, J. Apperley, J. Goldman

Research output: Contribution to journalArticle

40 Citations (Scopus)
Original languageEnglish
Pages (from-to)1954-1959
Number of pages6
JournalLeukemia
Volume14
Issue number11
DOIs
Publication statusPublished - 2000

Keywords

  • intravenous busulfan myeloablation pharmacokinetics toxicity bone-marrow transplantation venoocclusive disease liposomal busulfan pharmacokinetics bioavailability formulation disposition children plasma chemotherapy

Cite this